ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "#174: The Story of Tessera Therapeutics with CEO and co-founder Geoff von Maltzahn 🥼"
Episode Synopsis
This week, James is joined by Geoff von Maltzahn, CEO and co-founder at Tessera Therapeutics. Tessera is an early-stage biotech start-up that launched this summer with $50M in financing to pioneer a new category in ‘gene writing.’ Going even further than CRISPR, Tessera’s gene writing technology presents the potential to cure genetic disorders, cancers, and even infectious diseases like COVID-19. Geoffrey was awarded a Ph.D. in biomedical engineering and medical physics from MIT.
Get in touch with Geoff: @GVMaltzahn | https://www.linkedin.com/in/geoffrey-von-maltzahn-7a6b755a/
Subscribe to Healthtech Pigeon 🐦www.healthtechpigeon.com
Get in touch: www.jamessomauroo.com | www.somx.co.uk
More episodes of the podcast The Healthtech Podcast
#416 Steve Roest from PocDoc: Is Point-of-Care Testing the Future of Preventative Health?
26/09/2025
#415 Rachel Murphy from The Grafter: How Founders Can Grow, Raise, and Exit The Smart Way
17/09/2025
In God we trust